Paper32835331
Low rate of bacterial co-infection in patients with COVID-19.
Adler H and 4 others. Lancet Microbe, 2020. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Low rate of bacterial co-infection in patients with COVID-19. Papers, record 32835331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32835331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| COVID-19 | Major topic |
| Coinfection | Major topic |
| Bacteria | |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 32835323 | Co-infections: potentially lethal and unexplored in COVID-19. | https://conductscience.org/library/papers/32835323 |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32298228 | Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19. | Emerg Infect Dis | 2020 | https://conductscience.org/library/papers/32298228 | PubMed |
| 2 | 32835323 | Co-infections: potentially lethal and unexplored in COVID-19. | Lancet Microbe | 2020 | https://conductscience.org/library/papers/32835323 | PubMed |
| 3 | 32314699 | Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/32314699 | PubMed |
| 4 | 19783532 | BTS guidelines for the management of community acquired pneumonia in adults: update 2009. | Thorax | 2009 | https://conductscience.org/library/papers/19783532 | PubMed |
| 5 | 32308532 | First COVID-19 infections in the Philippines: a case report. | Trop Med Health | 2020 | https://conductscience.org/library/papers/32308532 | PubMed |
| 6 | 23321766 | Bacterial coinfection in influenza: a grand rounds review. | JAMA | 2013 | https://conductscience.org/library/papers/23321766 | PubMed |
| 7 | 5092152 | Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic. | Am J Med Sci | 1971 | https://conductscience.org/library/papers/5092152 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41884792 | Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study). | Ther Adv Infect Dis | 2026 | https://conductscience.org/library/papers/41884792 | PubMed |
| 37887248 | Secondary and Co-Infections in Hospitalized COVID-19 Patients: A Multicenter Cross-Sectional Study in Malaysia. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37887248 | PubMed |
| 37559639 | Prevalence of early bacterial co-infection in hospitalized patients with COVID-19 pneumonia: a retrospective study. | J Thorac Dis | 2023 | https://conductscience.org/library/papers/37559639 | PubMed |
| 37374189 | The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37374189 | PubMed |
| 36654638 | Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab. | Cureus | 2022 | https://conductscience.org/library/papers/36654638 | PubMed |
| 36572705 | Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan. | Sci Rep | 2022 | https://conductscience.org/library/papers/36572705 | PubMed |
| 36557623 | Incidence and Microbiology of Hospital-Acquired Infections in COVID-19 Patients between the First and the Second Outbreak of the SARS-CoV-2 Pandemic: A Retrospective, Observational Study. | Microorganisms | 2022 | https://conductscience.org/library/papers/36557623 | PubMed |
| 36464477 | SARS-CoV-2 and Legionella pneumophila coinfection. | Enferm Infecc Microbiol Clin (Engl Ed) | 2022 | https://conductscience.org/library/papers/36464477 | PubMed |
| 36345840 | Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens? | Epidemiol Infect | 2022 | https://conductscience.org/library/papers/36345840 | PubMed |
| 36211412 | Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19. | Front Immunol | 2022 | https://conductscience.org/library/papers/36211412 | PubMed |
| 36189314 | IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. | Front Immunol | 2022 | https://conductscience.org/library/papers/36189314 | PubMed |
| 35723762 | Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study. | Angiogenesis | 2022 | https://conductscience.org/library/papers/35723762 | PubMed |
| 35720435 | Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients. | Biofilm | 2022 | https://conductscience.org/library/papers/35720435 | PubMed |
| 35634338 | Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2. | Front Immunol | 2022 | https://conductscience.org/library/papers/35634338 | PubMed |
| 35593963 | Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. | Mol Biomed | 2022 | https://conductscience.org/library/papers/35593963 | PubMed |
| 35507600 | Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study. | PLoS One | 2022 | https://conductscience.org/library/papers/35507600 | PubMed |
| 35371794 | Secondary Bacterial Infection Rates Among Patients With COVID-19. | Cureus | 2022 | https://conductscience.org/library/papers/35371794 | PubMed |
| 35336074 | SARS-CoV-2-Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020-2021). | Microorganisms | 2022 | https://conductscience.org/library/papers/35336074 | PubMed |
| 35257905 | Bacterial co-infection at hospital admission in patients with COVID-19. | Int J Infect Dis | 2022 | https://conductscience.org/library/papers/35257905 | PubMed |
| 35246169 | Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study. | Virol J | 2022 | https://conductscience.org/library/papers/35246169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32835331
GET https://conductscience.org/api/papers/v1/32835331/cited_by?page=2